Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/04/2026 | Q4 2025 | N/A | $0.02 | N/A | N/A | $0 |
| 11/18/2025 | Q3 2025 | N/A | $0.06 | N/A | N/A | $0 |
| 08/13/2025 | Q2 2025 | N/A | $0.07 | N/A | N/A | $0 |
| 05/14/2025 | Q1 2025 | N/A | $0.02 | N/A | N/A | $0 |
| 03/28/2025 | Q4 2024 | N/A | $0.05 | N/A | N/A | $0 |
| 11/13/2024 | Q3 2024 | N/A | $0.08 | N/A | N/A | $0 |
| 08/09/2024 | Q2 2024 | N/A | $0.07 | N/A | N/A | $0 |
| 05/13/2024 | Q1 2024 | N/A | $0.08 | N/A | N/A | $0 |
| 03/25/2024 | Q4 2023 | N/A | $0.02 | N/A | N/A | $0 |
The conference call for Aimei Health Technology Co Ltd's latest earnings report can be listened to online.
The conference call transcript for Aimei Health Technology Co Ltd's latest earnings report can be read online.
Aimei Health Technology Co Ltd (:AFJK) has a recorded net income of $1.06 M.Aimei Health Technology Co Ltd has generated $0.17 earnings per share over the last four quarters.
Aimei Health Technology Co Ltd (:AFJK) has a price-to-earnings ratio of 171.1 and price/earnings-to-growth ratio is -4.36.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED